{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:48:06Z","timestamp":1791985686548,"version":"4.4.0"},"reference-count":0,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,13]]},"DOI":"10.7759\/cureus.3133","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T18:16:57Z","timestamp":1534184217000},"source":"Crossref","is-referenced-by-count":2,"title":["The Relationship of UGT2B15 Pharmacogenetics and Lorazepam for Anxiety"],"prefix":"10.7759","author":[{"given":"Nathan R","family":"Ching","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna K","family":"Alzghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed K","family":"Alzghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/13678-the-relationship-of-ugt2b15-pharmacogenetics-and-lorazepam-for-anxiety","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:16:54Z","timestamp":1707506214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/13678-the-relationship-of-ugt2b15-pharmacogenetics-and-lorazepam-for-anxiety"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,13]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7759\/cureus.3133","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,13]]}}}